Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Inflammatory Bowel Diseases · 01.02.2024 · 30 (2) · 230-239
DOI: 10.1093/ibd/izad061 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 12.04.2023. Verfasst von Yakup Kilic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University College London Hospitals NHS Foundation Trust, 235 Euston Road, London NW1 2BU, United Kingdom. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease, Pyoderma Gangrenosum. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
Background
Inflammatory bowel disease (IBD) is a multisystem disease impacting various body systems including musculoskeletal, ocular, skin, hepatobiliary, pulmonary, cardiac, and haematological systems. The extraintestinal manifestations of IBD are frequent, common in both ulcerative colitis (UC) and Crohn’s disease (CD), and impact the morbidity and mortality of patients.
Methods
The Embase, Embase classic, and PubMed databases were searched between January 1979 and December 2021. A random effects model was performed to find the pooled prevalence of joint, ocular, and skin extraintestinal manifestations of UC and CD.
Results
Fifty-two studies were included that reported on 352 454 patients. The prevalence of at least 1 joint, ocular, or skin extraintestinal manifestation in all IBD, UC, and CD was 24%, 27%, and 35% respectively. The prevalence between UC and CD were similar for pyoderma gangrenosum and axial joint manifestations. Ocular manifestations were found to be more common in CD than in UC. Peripheral joint manifestations and erythema nodosum were found to be more common in CD than UC.
Discussion
To our knowledge, this is the first meta-analysis that reports on the prevalence of at least 1 joint, ocular, or skin extraintestinal manifestation in IBD. Our results are largely consistent with figures and statements quoted in the literature. However, our findings are based on significantly larger cohort sizes. Thus, our results have the potential to better power studies and more accurately counsel patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, University College London Hospitals NHS Foundation Trust, 235 Euston Road, London NW1 2BU, United Kingdom.
- Department of Gastroenterology, Northern Hospital, Epping, Melbourne, Australia.
- Department of Cardiology, Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, Uxbridge, UB9 6JH, United Kingdom.
- Department of Gastroenterology, Whipps Cross University Hospital, Barts Health NHS Trust, Whipps Cross Road, London E11 1NR, United Kingdom.
- Department of Gastroenterology, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Bordesley Green East, Birmingham, B9 5SS, United Kingdom.
- Department of Medicine, University of Melbourne, Parkville, Melbourne, Australia.
ORCID-Profile: Danujan Sriranganathan
Zitieren
APA
Kilic, Y., Kamal, S., Jaffar, F., Sriranganathan, D., Quraishi, M. N., & Segal, J. P. (2024). Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflammatory Bowel Diseases, 30(2), 230-239. https://doi.org/10.1093/ibd/izad061
Vancouver
Kilic Y, Kamal S, Jaffar F, Sriranganathan D, Quraishi MN, Segal JP. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflammatory Bowel Diseases. 2024;30(2):230-239. doi:10.1093/ibd/izad061
BibTeX
@article{Kilic2024,
author = {Kilic, Yakup and Kamal, Shahed and Jaffar, Farah and Sriranganathan, Danujan and Quraishi, Mohammed Nabil and Segal, Jonathan P},
title = {Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis},
journal = {Inflammatory Bowel Diseases},
year = {2024},
volume = {30},
number = {2},
pages = {230--239},
doi = {10.1093/ibd/izad061}
}
EUVIMED